Catalytic autoantibodies in multiple sclerosis: Pathogenetic and clinical aspects
- 1 January 2005
- journal article
- research article
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 139 (1) , 85-88
- https://doi.org/10.1007/s10517-005-0220-7
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Multiple sclerosisJournal of Clinical Investigation, 2004
- B cells in multiple sclerosisFrontiers in Bioscience-Landmark, 2004
- Transcriptional analysis of targets in multiple sclerosisNature Reviews Immunology, 2003
- Catalytic antibodies in clinical and experimental pathology: human and mouse modelsJournal of Immunological Methods, 2002
- Catalytic heterogeneity of polyclonal DNA-hydrolyzing antibodies from the sera of patients with multiple sclerosisImmunology Letters, 2001
- Multiple SclerosisNew England Journal of Medicine, 2000
- DNA-hydrolyzing autoantibodiesApplied Biochemistry and Biotechnology, 1994
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983